eluting stent

DES angioplastia primaria

DES in primary PCI: The Best Option?

Courtesy of Dr. Brian Nazareth Donato.   The relative safety of drug-eluting stents (DES) and conventional bare-metal stents (BMS) in primary angioplasty (percutaneous coronary intervention, PCI) in patients with ST elevation myocardial infarction (STEMI) is still subject of debate.   A search was carried out using Medline, CENTRAL, EMBASE, TCTMD and Cardiosource. There were 9673 patients included,...

plataformas bioabsorbibles

BVS: Comparable to Second-Generation DES in Complex Lesions

A center carrying out a mid- to long-term follow-up of the performance of everolimus-eluting bioresorbable scaffolds (Absorb) observed that this new device has an acceptable rate of major cardiovascular events, when compared to second-generation drug-eluting stents. Furthermore, although the population was complex and non-selected, no cases of early thrombosis were reported. This study enrolled 249 patients...

doble antiagregación plaquetaria

DAPT after PCI with EES: 6 or 12 Months?

Original Title: 6-Month versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation. The IVUS-XPL Randomized Clinical Trial. Reference: Hong et al. JACC Cardiovasc Interv. 2016 May 11. [Epub ahead of print]   Courtesy of Dr. Brian Nazareth Donato.    This publication stems from the IVUS-XPL published by JAMA in November 2015. This study presents outcomes on the...

stent liberador de drogas protusion de placa

Tissue Protrusion after DES: Adverse Events at Long Term?

Original Title: Tissue Protrusion after Stent Implantation. An ADAPT-DES Intravascular Ultrasound Substudy. Reference: Fuyu Qiu et al. J Am Coll Cardiol Intv. 2016;9(14):1499-1507.   After DES implantation we may observe tissue protrusion (plaque or thrombus) relatively often, especially in unstable lesions; however, its clinical impact has not been studied. The aim of this study was...

radioterapia angioplastia

Radiotherapy: Post PCI Cardiovascular Death Predictor

Original Title: Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated with Percutaneous Coronary Intervention. Reference: Reed GW et al.  Circ Cardiovasc Interv. 2016 Jun;9(6).   Courtesy of Dr. Brian Nazareth Donato.   Radiotherapy is often used to treat malignant tumors; however, it is associated with adverse cardiovascular effects such as constrictive pericarditis, valve deterioration...

Discover which were the best e-posters

FIRST PLACE 114 THE IMPACT OF POST-PROCEDURAL ASYMMETRY, EXPANSION AND ECCENTRICITY OF BIORESORBABLE EVEROLIMUS-ELUTING SCAFFOLD AND METALLIC EVEROLIMUS-ELUTING STENT ON CLINICAL OUTCOMES IN THE ABSORB II TRIAL PANNIPA SUWANNASOM1; YOHEI SOTOMI1; RAFAEL CAVALCANTE E SILVA2; CARLOS MACAYA3; JOHN A ORMINSTON4; JONATHAN HILL5; MACIEJ LESIAK6; BERNARD CHEVALIER7; PATRICK W SERRUYS8; YOSHINOBU ONUMA2 1.ACADEMIC MEDICAL CENTER, HOLLAND;...

angioplastia de tronco

Left main PCI: Requiem for the Syntax score?

Original Title: Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity. Reference: JACC Cardiovascular Interventions. Doi: 10.1016/j.jcin.2016.02.016. Courtesy of Dr. Agustín Vecchia.   In patients with unprotected left main disease (ULMD) associated to complex coronary anatomy, choosing a revascularization strategy can be challenging. Current guidelines recommend surgery for...

Zilver-PTX

Zilver PTX: Maintains efficacy in real life most challenging lesions?

Original Title: Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan 12-Month Results. Reference: Hiroyoshi Yokoi et al. J Am Coll Cardiol Intv. 2016;9(3):271-277.   This multicenter prospective study carried out in Japan assessed the paclitaxel eluting stent Zilver PTX in an unselected real world population very different to...

¿Desescalar la doble antiagregación es el nuevo paradigma?

Optimal Duration of Dual Antiplatelet Therapy: New ACC-AHA Guidelines

Original Title: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease. Reference: Levine GN et al. Circulation. 2016 Mar 29. [Epub ahead of print]. Courtesy of Dr. Alejandro Lakowsky.  The new ACC-AHAGuidelines on the optimal duration of dual antiplatelet therapy(DAPT) in patients with coronary artery disease have just been...

Mechanisms of Very Late DES Thrombosis by OCT

Original Title: Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography. Reference: Masanori Taniwaki et al. Circulation. 2016 Feb 16;133(7):650-60.   The physiopathological mechanisms behind DES thrombosis have not been fully described yet. The potential causes behind this adverse event were assessed using optical computed tomography (OCT). Between August 2010 and December 2014,...

Top